Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1995-2-8
|
pubmed:abstractText |
To investigate whether increased availability of lipids affects glucose metabolism in healthy postabsorptive men when lipid and glucose are infused in amounts used in parenteral nutrition, we infused glucose (4 mg/kg.min-1) for 6 hours and clamped plasma glucose at basal level during the first 3 hours. After 3 hours, either long-chain triglycerides (LCTs) (0.07 g/kg.h-1) (n = 7) or a mixture of LCTs and medium-chain triglycerides (MCTs) (MCTs/LCTs, 50/50%, 0.07 g/kg.h-1) (n = 7) was administered, and the infusion rates of glucose and insulin were unchanged compared with the first 3 hours. In a control study, glucose was infused for a period of 6 hours without the lipid infusion (n = 5). After 6 hours, the plasma glucose concentration and glucose tissue uptake were not affected by LCT or MCT/LCT infusion. Nonetheless, glucose oxidation decreased in the LCT group (from 6.42 +/- 1.04 to 2.31 +/- 0.85 mumol/kg.min-1, p < .001) and in the MCT/LCT group (from 7.62 +/- 1.50 to 5.50 +/- 0.76 mumol/kg.min-1, p < .01) but not in the control group. Concentrations of the glucoregulatory hormones were not different among the three groups. In conclusion, MCTs/LCTs administered concomitantly with glucose infusion, in amounts similar to those used in total parenteral nutrition, inhibit glucose oxidation without affecting glucose tissue uptake, just as LCTs do.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Emulsions,
http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids, Nonesterified,
http://linkedlifedata.com/resource/pubmed/chemical/Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0148-6071
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
436-41
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7815676-Adult,
pubmed-meshheading:7815676-Calorimetry, Indirect,
pubmed-meshheading:7815676-Emulsions,
pubmed-meshheading:7815676-Fatty Acids, Nonesterified,
pubmed-meshheading:7815676-Glucose,
pubmed-meshheading:7815676-Humans,
pubmed-meshheading:7815676-Infusions, Intravenous,
pubmed-meshheading:7815676-Insulin,
pubmed-meshheading:7815676-Male,
pubmed-meshheading:7815676-Oxidation-Reduction,
pubmed-meshheading:7815676-Structure-Activity Relationship,
pubmed-meshheading:7815676-Triglycerides
|
pubmed:articleTitle |
Infusion of long-chain or medium-chain triglycerides inhibits peripheral glucose metabolism in men.
|
pubmed:affiliation |
Department of Internal Medicine, University of Amsterdam, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|